Valeo Pharma Inc CEO Steve Saviuk joined Proactive's Stephen Gunnion to discuss the company's strong position on the Globe and Mail's Report on Business annual list of Canada’s top-growing companies.

The company placed 151 out of 425 companies, with a three-year growth rate of 322%.

Saviuk explained that the rankings are calculated on revenue growth, and the exponential growth in the company's Enerzair asthma therapy helped it secure its position.

Despite launching less than two years ago, he said Enerzair already ranks second in Canada's inhaled asthma drug market, accounting for approximately one out of every five prescriptions.

Given the current trajectory, Saviuk said the company may rank even higher in 2024.

The Report on Business magazine launched Canada’s Top Growing Companies ranking in 2019 and companies have to complete an in-depth application process and fulfill certain requirements in order to be recognized.

Valeo Pharma is a fast-growing Canadian pharmaceutical company dedicated to the commercialization of innovative prescription products in Canada with a focus on Respiratory/Allergy, Ophthalmology and Hospital Specialty Products.

#ProactiveInvestors #ValeoPharma #HealthcareInnovation #SteveSaviuk #TopCanadianCompanies #PharmaceuticalGrowth #Entersair #AsthmaTherapy #HealthcareBenefits #PrescriptionGrowth #InnovativeProducts #CanadianHealthcare #PharmaceuticalIndustry #MedicalInnovation #CanadaBusiness #CorporateAchievement #CompanyGrowth #RevenueRanking #HealthcareSolutions #PrescriptionMedications #MedicalTechnology #CanadianInnovation #HealthcareLeadership #PharmaNews #BusinessSuccess #HealthcareTrends #GrowthStrategies

In today's Crypto Report we take a look at the wider cryptocurrency landscape, and how Bitcoin is solidifying its market dominance, outpacing second largest cryptocurrency, Ethereum.

Amidst legal challenges faced by Ripple and FTX's founder Sam Bankman-Fried, Bitcoin's grip on the market strengthens, consistently gaining against the US dollar.

However, it's yet to break past the pivotal 200-day moving average. Ethereum, meanwhile, faces potential back-to-back losses, struggling to keep pace this month.

Ripple's XRP briefly surged, thanks to a legal win against the US Securities and Exchange Commission, but this momentum was short-lived. Among altcoins, Solana emerges as the week's star, while Binance's BNB and Dogecoin lag behind.

As the global cryptocurrency market cap inches up by 0.6%, traders remain watchful, influenced by the US Federal Reserve's decisions. Stay updated in this fast-paced crypto world, where market shifts are the only constant.

#ProactiveInvestors #BitcoinDominance #CryptocurrencyNews #EthereumTrends #RippleLegalBattle #SolanaRise #CryptoMarketUpdate #USFederalReserve #BitcoinVsDollar #AltcoinPerformance #CryptoShifts

#invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Good morning from London where the FTSE 100 is trading at its lowest level since August at just above 7,400 points. Analysts from Barclays Bank this morning are saying that a prolonged slump in stock markets is the only way to stop a recent dramatic surge in bond yields.

Looking at a few of this morning’s other big stories now and Metro Bank has revealed its looking for £600 million to shore up its finances – their share price are down 20% on the day so far as a result.

Imperial Brands shares moved in the other direction, trading higher on the launch of a new £1.1 billion share buyback. The cigarette giant is yet to comment on Prime Minister Rishi Sunak’s decision to progressively outlaw smoking here in the UK.

The National Grid also climbed early on after reassuring investors that trading was as expected over the first half of the year, plotting it on course for an overall profit. News that Diversified Energy had scrapped plans to list in the US was also well-received, sending its stock higher as well.

And outside of the stock market property website Rightmove is saying this morning that average London rents have risen to yet another record of £2,637 a month, compared with £1,278 outside the capital, with an average of 25 people competing for each UK property between July and September.

#ProactiveInvestors #FTSE100 #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Lightwave Logic, Inc. (NASDAQ:LWLG) Chairperson and CEO Michael Lebby speaks to Proactive London from the sidelines of the ECOC (European Exhibition on Optical Communications) Exhibition 2023 in Glasgow.

Lebby gives a brief overview of the work Lightwave Logic is doing with its electro-optic polymer technology to help "speed up the internet" and highlights the "Most innovative Product – Hybrid PIC/Optical Integration Platform" award the company received at this week's event.

Looking ahead, Lebby highlighted the company's focus on deepening commercial interactions, having already secured their first commercial licensing deal in May.

"We're in lots of discussions with other folks that are interested in licensing our technology and also we're in discussions with folks looking at our technology itself for product sales. So what investors can expect to see is a lot more activity there... in general these are really exciting times for us."

#LightwaveLogic #MichaelLebby #InternetSpeed #OpticalCommunication #ElectroOpticPolymers #TechInnovation #InternetTechnology #IndustryAward #OpticalModulator #TechConference #InternetEnhancement #TechUpdate

#ProactiveInvestors #lightwave #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Northern Leaf CEO Don Perrott speaks to Thomas Warner from Proactive London about the Jersey-based medical cannabis company's progress towards a potential AIM-listing later this year.

Perrott gives an overview of the business and its achievements since being incorporated in 2019, highlighting its 100,000 square-foot glasshouse facility that produces six to eight tonnes of medical cannabis annually and its its EU Good Manufacturing Practice (GMP) and Good Clinical Practice (GCP certifications).

Perrott discusses the benefits the advantages of operating in Jersey, which include a supportive government and competitive electricity costs.

Northern Leaf is gearing up for a listing on AIM in the fourth quarter, with substantial progress already made in its IPO preparations.

Perrott emphasises the commitment to producing high-quality, consistent medical cannabis and says the company is "on the road in terms of sales" with a shipment already on its way to Australia and deliveries to the UK and Germany scheduled.

Perrott also expresses confidence in Northern Leaf's ability to navigate an often complex regulatory environment, saying that the company is "on top of regulations" and embracing the opportunities being created.

#DonPerrott #NorthernLeaf #MedicalCannabis #LondonListing #AIMListing #CannabisIndustry #JerseyCannabis #EUGMP #GCPcertified #CannabisProduction #CannabisRegulation #ProductiveLondonNewsroom #CannabisExports #MedicalCannabisQuality #CEOInterview

#ProactiveInvestors #NorthernLeaf #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

S&U PLC (LSE:SUS) chairman Anthony Coombs speaks to Thomas Warner from Proactive after the specialist motor finance & bridging lender released its interim results for the six months to 31 July.

Coombs gives an overview of how the business performed during the period, highlighting a 12% rise in revenues with a slight profit increase. Despite facing economic headwinds, reflected in current stock market valuations and high interest rates affecting business finance costs, he remains optimistic.

He notes concerns about the cost of living impacting their customers and emphasises the importance of sustainable loan repayments, especially in motor finance. The property market has seen a slowdown, with a potential 5% reduction in residential values. He says the company "has got to be careful in terms of our underwriting, we've got responsibilities not only in commercial terms but in maintaining excellent relationships with our customers."

However, S&U maintains conservative loan-to-value ratios and has witnessed excellent collections in their aspirin bridging operation. Coombs highlights the company's commitment to maintaining high standards in customer relations, especially with new regulatory measures in place.

He concludes by saying that while the economic and political landscape remains uncertain, S&U continues to prioritise customer service and fairness.

#AnthonyCoombs #S&UPLC #PropertyFinancing #MotorFinancing #EconomicHeadwinds #StockMarketValuations #InterestRates #CostOfLiving #LoanRepayments #ResidentialValues #AspirinBridging #CustomerRelations #FinancialRegulations #EconomicOutlook #BritishCompanies

#ProactiveInvestors #S&U #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Rainbow Rare Earths Ltd (LSE:RBW, OTC:RBWRF) CEO George Bennett speaks to Thomas Warner from Proactive after the magnet rare earth metals company announced a placing and the signing of a letter of intent with NEXUS Intertrade that will see the Rainbow Rare Earths clean up gypsum stockpiles for sale by NEXUS.

Bennett says that the £4.5mln placing was executed at a negligible discount to the market price and replenishes the funds used to secure 100% of the Phalaborwa project. The funds will also support the completion of their pilot plant and their DFS study, currently slated for Q2 2024.

Bennett also highlights the letter of intent with NEXUS Intertrade, emphasising Rainbow's commitment to making Phalaborwa an environmentally-friendly project. They are addressing environmental concerns by neutralising the acid water in the waste gypsum. Moreover, with gypsum deposits in South Africa expected to deplete by 2026-2027, Rainbow is poised to fill the gap, potentially selling between 40,000 to 100,000 tonnes annually, adding a significant new revenue stream to the company.

#RainbowRareEarths #GeorgeBennett #ProactiveLondon #MiningNews #EnvironmentalInitiatives #GypsumProject #MiningPlacing #RareEarths #SouthAfricaGypsum #MiningInterviews #SustainableMining #PillarWarProject #GFSStudy2024

#ProactiveInvestors #rareearth #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Invinity Energy Systems PLC (AIM:IES, OTCQX:IESVF) CEO Larry Zulch speaks to Thomas Warner from Proactive after the vanadium flow battery manufacturer announced two significant new developments.

The company has recently announced the sale of six of its shipping-container sized vanadium flow batteries to Taiwan's National Applied Research Laboratories, which collectively amount to 1.1 MWh of capacity. Zulch emphasises that vanadium flow batteries neither catch fire nor wear out, making them ideal for electrical infrastructure, and suggests that more orders from Taiwan may be forthcoming.

Invinity has also revealed that the US Department of Energy plans to fund projects that will use 84 MWh of Invinity's next-generation product, code-named "Mistral." Zulch explains the significance of the news, calling it a "major affirmation that we are headed in the direction of being able to make a big difference on the renewable infrastructure."

Over the next six months, Invinity plans to announce more energy storage projects and as well as more news from its partnership with Siemens Gamesa.

#InvinityEnergySystems #VanadiumFlowBatteries #RenewableEnergy #TaiwaneseNationalLaboratory #USDepartmentOfEnergy #EnergyStorage #LithiumAlternative #ProactiveLondon #LarryZulchInterview #Siemens #ElectricalInfrastructure #NextGenEnergyProduct

#ProactiveInvestors #Vanadium #batteries #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

ABx Group Ltd (ASX:ABX, OTC:AUSBF) Managing Director Mark Cooksey speaks to Thomas Warner about the the strategic minerals and chemicals company's progress with its projects in Tasmania and the Australian mainland.

Cooksey gives a brief overview of the business, saying that ABx is primarily focused on exploring rare earth elements in Tasmania as well as developing a novel process to convert industrial waste into essential industrial chemicals.

A significant highlight is their ionic clay rare earth deposit, similar to those mined in China, which is a cost-effective source of heavy rare earths for permanent magnets. Cooksey reveals that recent assays showed "by far the highest assay result to date" of over 17,000 PPM total rare earths including over 800ppm of dysprosium.

With promising results close to their drilling boundary, he sees scope for extending the resource.

Over the next two years, ABx aims to expand its rare earth resource, finalise metallurgical processes, and to be close to establishing its first commercial plant in Tasmania to recycle waste from Australian aluminium smelters.

#MarkCooksey #ABxGroup #ProactivInterview #RareEarthExploration #TasmaniaRailroad #IndustrialWasteRecycling #IonicClayDeposit #ASXListedCompany #AluminiumSmeltingWaste #RareEarthAssays #FutureOfMining #IndustrialChemicals #ResourceExpansion #ProactiveInvestors #InsertCompanyName #Abx #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews

Nuformix PLC (LSE:NFX) executive director Dr Dan Gooding speaks to Proactive after the pharmaceutical development company announced it is to receive new immediate and near-term milestone payments as part of an update to its NXP001 exclusive licensing agreement with Oxilio Ltd.

Dr. Gooding explains that Oxilio has now purchased patents from Nuformix that it had previously been licencing, resulting in significant near-term payments to Nuformix. This financial boost will aid Nuformix in advancing their unlicensed programs, specifically NXP002 and NXP004. Despite the patent sale, Nuformix retains future value from NXP001 through development milestones and royalties.

Dr. Gooding also highlights Nuformix's work with NXP002 on lung fibrosis, a severe disease with limited treatment options. He explains that Nuformix's approach of repurposing existing drugs means a reduction in research time and costs. NXP002 is a modified version of a drug initially approved in Japan for asthma and skin scarring treatment.

#Nuformix #DrDanGooding #DrugRedevelopment #NXP001 #Oxilio #LungFibrosis #NXP002 #DrugRepurposing #AsthmaTreatment #SkinScarring #ProactivInterview #MedicalInnovation #PharmaceuticalNews #TreatmentAdvancements #NuformixUpdate

#ProactiveInvestors #nuformix #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews